32488543|t|Perindopril ameliorates experimental Alzheimer's disease progression: role of amyloid beta degradation, central estrogen receptor and hyperlipidemic-lipid raft signaling.
32488543|a|Accumulating evidence indicates that over-stimulation of angiotensin-converting enzyme 1 (ACE1) activity is associated with beta-amyloid (Abeta) and phosphorylated tau (p-tau)-induced apoptosis, oxido-nitrosative neuroinflammatory stress and neurodegeneration in Alzheimer's disease (AD). Alternatively, activation of the ACE2, the metalloprotease neprilysin (Neutral Endopeptidase; NEP) and the insulin-degrading enzyme (IDE) could oppose the effects of ACE1 activation. We aim to investigate the relationship between ACE1/ACE2/NEP/IDE and amyloidogenic/hyperlipidemic-lipid raft signaling in hyperlipidemic AD model. Induction of AD was performed in ovariectomized female rats with high-fat high fructose diet (HFFD) feeding after 4 weeks following D-galactose injection (150 mg/kg). The brain-penetrating ACE1 inhibitor perindopril (0.5 mg/kg/day, p.o.) was administered on a daily basis for 30 days. Perindopril significantly decreased hippocampal expression of ACE1 and increased expression of ACE2, NEP and IDE. Perindopril markedly decreased Abeta1-42, improved lipid profile and ameliorated the lipid raft protein markers caveolin1 (CAV1) and flotillin 1 (FLOT1). This was accompanied by decreased expression of p-tau and enhancement of cholinergic neurotransmission, coupled with decreased oxido-nitrosative neuroinflammatory stress, enhancement of blood-brain barrier (BBB) functioning and lower expression of the apoptotic markers glial fibrillary acidic protein (GFAP), Bax and beta-tubulin. In addition, perindopril ameliorated histopathological damage and improved learning, cognitive and recognition impairment as well as depressive behavior in Morris water maze, Y maze, novel object recognition and forced swimming tests, respectively. Conclusively, perindopril could improve cognitive defects in AD rats, at least through activation of ACE2/NEP/IDE and inhibition of ACE1 and subsequent modulation of amyloidogenic/hyperlipidemic-lipid raft signaling and oxido-nitrosative stress.
32488543	0	11	Perindopril	Chemical	MESH:D020913
32488543	37	56	Alzheimer's disease	Disease	MESH:D000544
32488543	112	129	estrogen receptor	Gene	24890
32488543	149	154	lipid	Chemical	MESH:D008055
32488543	309	314	Abeta	Gene	54226
32488543	340	345	p-tau	Gene	29477
32488543	384	401	neuroinflammatory	Disease	MESH:D000090862
32488543	413	430	neurodegeneration	Disease	MESH:D019636
32488543	434	453	Alzheimer's disease	Disease	MESH:D000544
32488543	455	457	AD	Disease	MESH:D000544
32488543	493	497	ACE2	Gene	302668
32488543	519	529	neprilysin	Gene	24590
32488543	554	557	NEP	Gene	24590
32488543	567	591	insulin-degrading enzyme	Gene	25700
32488543	593	596	IDE	Gene	25700
32488543	695	699	ACE2	Gene	302668
32488543	700	703	NEP	Gene	24590
32488543	704	707	IDE	Gene	25700
32488543	712	725	amyloidogenic	Disease	
32488543	741	746	lipid	Chemical	MESH:D008055
32488543	780	782	AD	Disease	MESH:D000544
32488543	803	805	AD	Disease	MESH:D000544
32488543	845	849	rats	Species	10116
32488543	869	877	fructose	Chemical	MESH:D005632
32488543	922	933	D-galactose	Chemical	MESH:D005690
32488543	994	1005	perindopril	Chemical	MESH:D020913
32488543	1075	1086	Perindopril	Chemical	MESH:D020913
32488543	1170	1174	ACE2	Gene	302668
32488543	1176	1179	NEP	Gene	24590
32488543	1184	1187	IDE	Gene	25700
32488543	1189	1200	Perindopril	Chemical	MESH:D020913
32488543	1240	1245	lipid	Chemical	MESH:D008055
32488543	1274	1279	lipid	Chemical	MESH:D008055
32488543	1301	1310	caveolin1	Gene	25404
32488543	1312	1316	CAV1	Gene	25404
32488543	1322	1333	flotillin 1	Gene	64665
32488543	1335	1340	FLOT1	Gene	64665
32488543	1391	1396	p-tau	Gene	29477
32488543	1488	1505	neuroinflammatory	Disease	MESH:D000090862
32488543	1613	1644	glial fibrillary acidic protein	Gene	24387
32488543	1646	1650	GFAP	Gene	24387
32488543	1653	1656	Bax	Gene	24887
32488543	1688	1699	perindopril	Chemical	MESH:D020913
32488543	1760	1796	cognitive and recognition impairment	Disease	MESH:D003072
32488543	1808	1818	depressive	Disease	MESH:D003866
32488543	1938	1949	perindopril	Chemical	MESH:D020913
32488543	1964	1981	cognitive defects	Disease	MESH:D003072
32488543	1985	1987	AD	Disease	MESH:D000544
32488543	1988	1992	rats	Species	10116
32488543	2025	2029	ACE2	Gene	302668
32488543	2030	2033	NEP	Gene	24590
32488543	2034	2037	IDE	Gene	25700
32488543	2090	2103	amyloidogenic	Disease	
32488543	2119	2124	lipid	Chemical	MESH:D008055
32488543	Negative_Correlation	MESH:D020913	25404
32488543	Positive_Correlation	MESH:D020913	302668
32488543	Positive_Correlation	MESH:D005690	MESH:D000544
32488543	Association	MESH:D008055	64665
32488543	Positive_Correlation	MESH:D020913	24590
32488543	Negative_Correlation	MESH:D020913	MESH:D000544
32488543	Association	MESH:D008055	MESH:D020913
32488543	Negative_Correlation	MESH:D020913	MESH:D003866
32488543	Positive_Correlation	MESH:D005632	MESH:D000544
32488543	Positive_Correlation	MESH:D020913	25700
32488543	Association	MESH:D008055	25404
32488543	Negative_Correlation	MESH:D020913	24887
32488543	Negative_Correlation	MESH:D020913	24387
32488543	Negative_Correlation	MESH:D020913	MESH:D000090862
32488543	Negative_Correlation	MESH:D020913	29477
32488543	Negative_Correlation	MESH:D020913	64665
32488543	Positive_Correlation	MESH:D020913	MESH:D003072

